Effectiveness of Semaglutide in Overweight or Obese Patients With IgA Nephropathy Without Diabetes

Documenti analoghi

• A Case of IgA Nephropathy in a Patient With Sarcoidosis: Confirmation of Glomerular Galactose‐Deficient IgA1 Deposition
  di: Yoshitaka Shimizu, et al.
  Pubblicazione: (2025)
• IgA Nephropathy With Membranoproliferative Pattern and Resistance to Immunosuppressive Therapy in Two Patients With Cofactor I Pathogenic Variant
  di: Tommaso Mazzierli, et al.
  Pubblicazione: (2025)
• Current understanding and new insights in the treatment of IgA nephropathy
  di: Yuemiao Zhang, et al.
  Pubblicazione: (2024)
• Principles for Optimal Drug Selection in IgA Nephropathy—Time for Integrating Pathogenesis and Clinical Markers to Guide Therapy
  di: Yusuke Suzuki
  Pubblicazione: (2026)
• Prognostic Utility of the MEST‐C Score Combined With Clinical Parameters in Hispanic Patients With IgA Nephropathy
  di: Lyzinhawer Alza-Arcila, et al.
  Pubblicazione: (2025)